MKSI (MKSI)

$14.6B
Market Cap
49.6
P/E Ratio
1.92
Beta
0.45%
Dividend Yield
Piotroski 7/9Altman Z 2.4 Gray ZoneBeneish M -2.58 CleanROIC−WACC -8.4%

Quantitative Summary

Deterministic

Strong operational fundamentals (Piotroski 7/9) with Altman Z of 2.4.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital efficiency metrics present a nuanced picture where strong profitability is partially offset by modest asset utilization. Despite generating an ROIC of 5.3%, the DuPont decomposition reveals that returns are driven primarily by high leverage (Equity Multiplier at 3.23x) rather than superior margin expansion or rapid inventory turnover, with net margins holding steady at 7.5% against a robust gross margin of 46.7%. This structural reliance on financial leverage to achieve an ROE of 10.8%, combined with a revenue growth rate of 9.6%, suggests the business model prioritizes balance sheet expansion over organic operational scaling, yet maintains integrity evidenced by a high Piotroski F-Score of 7/9 and a low Beneish M-Score of -2.58 indicating minimal earnings manipulation risk.

Valuation multiples reflect significant optimism relative to historical norms and sector peers, with the current P/E ratio expanding to 49.6x. This premium pricing implies that market participants are anticipating sustained acceleration in growth rates far exceeding the recent 9.6% YoY trajectory. However, this aggressive valuation stands in stark contrast to a DCF-derived fair value of $87, suggesting a substantial discount exists between current trading levels and intrinsic worth based on discounted cash flow assumptions. The divergence highlights that the market is pricing in future upside while ignoring potential compression if growth fails to materialize at the assumed rate.

Insider activity introduces a notable counterweight to the bullish valuation thesis, as $18 million in net selling over the last 90 days signals executive caution regarding near-term equity levels or private placement opportunities rather than lack of confidence in long-term fundamentals. While the fundamental quality scores remain robust, the combination of elevated leverage-dependent returns and heavy insider offloading warrants scrutiny before assuming further upside potential without a corresponding increase in asset efficiency or margin expansion.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →11.7%13.7%15.7%
2%$108$78$57
3%$122$87$63
4%$140$98$70

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=13.7%, terminal growth 3%. Fair value $87 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
2.4
Altman Z-Score
Grey Zone — between 1.8 and 3.0 thresholds. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.58
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

46.7%
Gross Margin
7.5%
Net Margin
5.3%
ROIC
13.7%
WACC
ROIC − WACC Spread: -8.4%— Negative spread.
+9.6%
Revenue Growth (YoY)
+55.3%
Earnings Growth (YoY)
497.0M
Free Cash Flow
12%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

7.5%
Net Profit Margin
NI ÷ Revenue
×
0.45x
Asset Turnover
Revenue ÷ Assets
×
3.23x
Equity Multiplier
Assets ÷ Equity
=
10.8%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

2.23x
Debt / Equity
2.71x
Current Ratio
2.3x
Interest Coverage
4.0x
Net Debt / EBITDA
2.75%
FCF Yield
877.0M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$18M
Net Selling
0
Buy Transactions
13
Sale Transactions
2026-03-12MOLONEY JACQUELINE FSold 6/8 qtrsSale$72,705
2026-03-06TARANTO ERIC ROBERTSold 1/8 qtrsSale$1M
2026-03-02MORA ELIZABETH ASold 8/8 qtrsSale$71,832
2026-02-24SCHREINER JAMES ALANSold 3/8 qtrsSale$1M
2026-02-24COLELLA GERARD GSold 2/8 qtrsSale$5M

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $1.45
Act: $1.71
+17.5%
Q3
✓ Beat
Est: $1.64
Act: $1.77
+8.1%
Q2
✓ Beat
Est: $1.85
Act: $1.93
+4.1%
Q1
✓ Beat
Est: $2.46
Act: $2.47
+0.3%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

18.1
Forward P/E
PEG Ratio
5.36
Price/Book
1M
Avg Volume
$269.91
52W High
$54.84
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$2.0B
Tracked Passive Exposure
8
ETFs Holding MKSI
0.08%
Avg Weight in ETFs
$2.6T
Total ETF AUM

When investors buy or sell ETFs like MDYG or SPMD, the fund manager is mechanically forced to buy or sell MKSI shares regardless of MKSI's individual fundamentals. We estimate $2.0B of passive capital is structurally linked to MKSI through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in MKSI to visualize passive redemption contagion across ETFs and collateral stocks.

MKSI Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
MKSIEpicenterVTIETFVBETFVGTETFFLEXMed RiskFTILow RiskTWLOLow RiskCWLow RiskNVTLow Risk
MKSI Price Drop (%)0

If MKSI (MKSI) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies FLEX LTD (FLEX) as the most exposed collateral stock, sharing 2 ETFs with MKSI. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 15 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

MKSI Ownership Dynamics

Ticker
MKSI

Float lock-up computed from 15 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

MKSI Capital Efficiency

How efficiently does MKSI convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$497M
EBITDA
$877M
FCF Conversion
57%
Reinvestment Rate
43%
57% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
5.3%
ROIC − WACC Spread
-8.4%

MKSI converts 57% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. However, the ROIC-WACC spread is negative (-8.4%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1240$319.71$12,788.4
2026-05-115,213$313.21$1.6M
2026-05-0792$293.77$27,026.84
2026-05-0521,700$291.53$6.3M
2026-05-019,378$283.75$2.7M
2026-04-271,000$280.98$280,980
2026-04-228$273.77$2,190.16
2026-04-201,000$278.59$278,590
2026-04-1717,083$269.89$4.6M
2026-04-16180$269.00$48,420
2026-04-146,474$273.18$1.8M
2026-04-1320,098$268.77$5.4M
2026-04-011,068$229.81$245,437.08
2026-03-2756$225.12$12,606.72
2026-03-24900$235.02$211,518
2026-03-234$227.13$908.52
2026-03-204$236.85$947.4
2026-03-1022,620$218.36$4.9M
2026-03-061,880$230.45$433,246
2026-02-275,985$244.68$1.5M
2026-02-23181$259.27$46,927.87
2026-02-19343$250.36$85,873.48
2026-02-093,401$242.96$826,306.96
2026-02-06786$226.83$178,288.38
2026-01-30600$243.88$146,328
2026-01-222,420$220.73$534,166.6
2026-01-153$190.30$570.9
2026-01-0725$183.50$4,587.5
2026-01-0214$159.80$2,237.2
2025-12-226,355$159.56$1.0M

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare MKSI to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.